Many parts of Canada have begun to restart the economy and return to usual life. The prime minister has unveiled what needs to be done across the country. Reopening Canada is going to be based on a three-step plan so we can get to a new normal.
On May 22 during his daily address, Justin Trudeau revealed a three-step plan on how Canada can come back from COVID-19.
Firstly, testing needs to be scaled up. That will help identify and isolate cases.
Canada is working with provinces and territories to help get things needed for testing like swabs.
Secondly, contact tracing must be accelerated.
That helps to ensure that anyone who has come into contact with the virus is aware of that and can take the appropriate measures like self-isolating and getting tested.
To help with this, Statistics Canada has 1,700 interviewers than can make up to 20,000 tracing calls a day.
There are also other federal employees that can make 3,600 calls every day of the week.
All of this could help provinces and territories with backlogs.
Thirdly, data collected has to be shared between provinces and territories to help track the spread of the virus.
"We aren't out of the woods yet," Trudeau said.
He also noted that we must proceed with caution now.
PM Trudeau on necessary steps to enable reopening of economy amid #COVID19: —testing capacity expansion (PM says f… https://t.co/hH4P7N9BjL— CPAC (@CPAC) 1590158954
During this pandemic, all levels of government have been working together to protect Canadians.
Trudeau noted that it's important for people across the country to know that.
He said the one common goal is protecting Canadians and that life was turned upside down overnight because of COVID-19.
While provinces and territories are managing contact tracing differently, the federal government is there to help with workers who can make calls every day.
The PM pointed out that Ontario has asked for support with that.
Last month Trudeau unveiled another three-pillar plan, which outlined Canada's approach to finding a COVID-19 vaccine. It includes research, support for clinical trials, and amping up national testing and modelling.